FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922971216> ?p ?o ?g. }

• W2922971216 endingPage "2436" @default.
• W2922971216 startingPage "2428" @default.
• W2922971216 abstract "Treatment of hepatitis C virus (HCV) infection has been historically challenging due the high viral genetic complexity wherein there are eight distinct genotypes and at least 86 viral subtypes. While HCV NS3/4A protease inhibitors are an established treatment option for genotype 1 infection, limited coverage of genotypes 2 and/or 3 combined with serum alanine transaminase (ALT) elevations for some compounds has limited the broad utility of this therapeutic class. Our discovery efforts were focused on identifying an NS3/4A protease inhibitor with pan-genotypic antiviral activity, improved coverage of resistance associated substitutions, and a decreased risk of hepatotoxicity. Towards this goal, distinct interactions with the conserved catalytic triad of the NS3/4A protease were identified that improved genotype 3 antiviral activity. We further discovered that protein adduct formation strongly correlated with clinical ALT elevation for this therapeutic class. Improving metabolic stability and decreasing protein adduct formation through structural modifications ultimately resulted in voxilaprevir. Voxilaprevir, in combination with sofosbuvir and velpatasvir, has demonstrated pan-genotypic antiviral clinical activity. Furthermore, hepatotoxicity was not observed in Phase 3 clinical trials with voxilaprevir, consistent with our design strategy. Vosevi® (sofosbuvir, velpatasvir, and voxilaprevir) is now an approved pan-genotypic treatment option for the most difficult-to-cure individuals who have previously failed direct acting antiviral therapy." @default.
• W2922971216 created "2019-04-01" @default.
• W2922971216 creator A5001687703 @default.
• W2922971216 creator A5003925483 @default.
• W2922971216 creator A5005481580 @default.
• W2922971216 creator A5011485982 @default.
• W2922971216 creator A5011507959 @default.
• W2922971216 creator A5011964130 @default.
• W2922971216 creator A5012991703 @default.
• W2922971216 creator A5016750075 @default.
• W2922971216 creator A5018994349 @default.
• W2922971216 creator A5028902162 @default.
• W2922971216 creator A5030217369 @default.
• W2922971216 creator A5046691170 @default.
• W2922971216 creator A5059119556 @default.
• W2922971216 creator A5061297737 @default.
• W2922971216 creator A5065465981 @default.
• W2922971216 creator A5066967694 @default.
• W2922971216 creator A5067517289 @default.
• W2922971216 creator A5067701446 @default.
• W2922971216 creator A5069610312 @default.
• W2922971216 creator A5075527557 @default.
• W2922971216 creator A5078343013 @default.
• W2922971216 creator A5087080135 @default.
• W2922971216 creator A5087813809 @default.
• W2922971216 creator A5090989332 @default.
• W2922971216 creator A5091216332 @default.
• W2922971216 creator A5091668231 @default.
• W2922971216 date "2019-08-01" @default.
• W2922971216 modified "2023-10-13" @default.
• W2922971216 title "Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®" @default.
• W2922971216 cites W1959704808 @default.
• W2922971216 cites W1966998996 @default.
• W2922971216 cites W1967785127 @default.
• W2922971216 cites W1975253652 @default.
• W2922971216 cites W1991470366 @default.
• W2922971216 cites W2012503063 @default.
• W2922971216 cites W2028026620 @default.
• W2922971216 cites W2030542598 @default.
• W2922971216 cites W2043566947 @default.
• W2922971216 cites W2064285218 @default.
• W2922971216 cites W2079770202 @default.
• W2922971216 cites W2080696565 @default.
• W2922971216 cites W2101016189 @default.
• W2922971216 cites W2121119506 @default.
• W2922971216 cites W2139670693 @default.
• W2922971216 cites W2141361007 @default.
• W2922971216 cites W2142165617 @default.
• W2922971216 cites W2227911728 @default.
• W2922971216 cites W2289667014 @default.
• W2922971216 cites W2295408863 @default.
• W2922971216 cites W2314083131 @default.
• W2922971216 cites W2318156787 @default.
• W2922971216 cites W2320330796 @default.
• W2922971216 cites W2512236949 @default.
• W2922971216 cites W252033410 @default.
• W2922971216 cites W2559485231 @default.
• W2922971216 cites W2578013986 @default.
• W2922971216 cites W2595869519 @default.
• W2922971216 cites W2605116305 @default.
• W2922971216 cites W2617500612 @default.
• W2922971216 cites W2765212316 @default.
• W2922971216 cites W2765666958 @default.
• W2922971216 cites W2944286011 @default.
• W2922971216 cites W4245344375 @default.
• W2922971216 doi "https://doi.org/10.1016/j.bmcl.2019.03.037" @default.
• W2922971216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31133531" @default.
• W2922971216 hasPublicationYear "2019" @default.
• W2922971216 type Work @default.
• W2922971216 sameAs 2922971216 @default.
• W2922971216 citedByCount "49" @default.
• W2922971216 countsByYear W29229712162019 @default.
• W2922971216 countsByYear W29229712162020 @default.
• W2922971216 countsByYear W29229712162021 @default.
• W2922971216 countsByYear W29229712162022 @default.
• W2922971216 countsByYear W29229712162023 @default.
• W2922971216 crossrefType "journal-article" @default.
• W2922971216 hasAuthorship W2922971216A5001687703 @default.
• W2922971216 hasAuthorship W2922971216A5003925483 @default.
• W2922971216 hasAuthorship W2922971216A5005481580 @default.
• W2922971216 hasAuthorship W2922971216A5011485982 @default.
• W2922971216 hasAuthorship W2922971216A5011507959 @default.
• W2922971216 hasAuthorship W2922971216A5011964130 @default.
• W2922971216 hasAuthorship W2922971216A5012991703 @default.
• W2922971216 hasAuthorship W2922971216A5016750075 @default.
• W2922971216 hasAuthorship W2922971216A5018994349 @default.
• W2922971216 hasAuthorship W2922971216A5028902162 @default.
• W2922971216 hasAuthorship W2922971216A5030217369 @default.
• W2922971216 hasAuthorship W2922971216A5046691170 @default.
• W2922971216 hasAuthorship W2922971216A5059119556 @default.
• W2922971216 hasAuthorship W2922971216A5061297737 @default.
• W2922971216 hasAuthorship W2922971216A5065465981 @default.
• W2922971216 hasAuthorship W2922971216A5066967694 @default.
• W2922971216 hasAuthorship W2922971216A5067517289 @default.
• W2922971216 hasAuthorship W2922971216A5067701446 @default.
• W2922971216 hasAuthorship W2922971216A5069610312 @default.
• W2922971216 hasAuthorship W2922971216A5075527557 @default.
• W2922971216 hasAuthorship W2922971216A5078343013 @default.

• next